•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S00520 Summary:

BILL NOS00520
 
SAME ASSAME AS A00686
 
SPONSORPERSAUD
 
COSPNSRADDABBO, BORRELLO, CLEARE, COMRIE, FAHY, JACKSON, PALUMBO, ROLISON, WEBER, WEIK
 
MLTSPNSR
 
Add §2404-e, Pub Health L
 
Ensures ovarian cancer survivors have the right to access screenings for health conditions.
Go to top

S00520 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                           520
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                       (Prefiled)
 
                                     January 8, 2025
                                       ___________
 
        Introduced by Sens. PERSAUD, BORRELLO, CLEARE, COMRIE, PALUMBO, ROLISON,
          WEBER,  WEIK -- read twice and ordered printed, and when printed to be
          committed to the Committee on Women's Issues
 
        AN ACT to amend the public health law, in relation to  ensuring  ovarian
          cancer survivors have the right to access screenings for health condi-
          tions
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The public health law is amended by adding  a  new  section
     2  2404-e to read as follows:
     3    §  2404-e.  Ovarian  cancer;  right  to  screenings.  No person with a
     4  personal history of ovarian cancer shall be denied  genetic  testing  or
     5  genomic  tumor  profiling  for inherited germline mutations and acquired
     6  somatic mutations, respectively. In general, such testing shall  not  be
     7  subject  to  frequency  caps or other limitations and shall include, but
     8  not be limited to:
     9    (a) genetic mutations in BRCA1 and BRCA2 genes;
    10    (b) genetic mutations associated with Lynch syndrome;
    11    (c) rearrangement analysis of all coding exons associated with ovarian
    12  cancer; and
    13    (d) additional mutations if medically necessary  and  appropriate,  as
    14  determined by the health care professional treating the individual.
    15    § 2. This act shall take effect immediately.
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02193-01-5
Go to top